• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺血性心肌病主要心律失常结局的预测:正电子发射断层扫描/计算机断层扫描中冬眠心肌的价值

Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography.

作者信息

Kovacs Boldizsar, Gllareva Valon, Ruschitzka Frank, Duru Firat, Kaufmann Philipp A, Buechel Ronny R, Benz Dominik C, Saguner Ardan M

机构信息

Department of Cardiology, University Heart Center, University Hospital Zurich, Raemistrasse 100, 8091 Zurich, Switzerland.

Division of Cardiology, Department of Internal Medicine, University of Michigan, Ann Arbor, USA.

出版信息

Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):30-37. doi: 10.1093/ehjci/jeae232.

DOI:10.1093/ehjci/jeae232
PMID:39213366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11687117/
Abstract

AIMS

Known predictors of major arrhythmic events (MAEs) in patients with ischaemic cardiomyopathy (ICM) include previous MAE and left ventricular ejection fraction (LVEF) ≤ 35%. Myocardial scars detected by perfusion imaging in ICM have been linked to MAE, but the prognostic significance of hibernating myocardium (HM) is unclear. The objective was to predict MAEs from combined 13N-ammonia (NH3) and 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in ICM.

METHODS AND RESULTS

Consecutive patients with ICM undergoing combined NH3- and FDG-PET/CT were included. HM was quantified in relation to total left ventricular myocardium (i.e. ≥7% is large). The primary outcome was MAEs [sudden cardiac death, implantable cardioverter defibrillator (ICD) therapy, and sustained ventricular tachycardia/fibrillation].Among 254 patients, median baseline LVEF was 35% [interquartile range (IQR) 28-45] and 10% had an ICD. PET/CT identified ischaemia in 94 (37%), scar in 229 (90%), and HM in 195 (77%) patients. Over a median follow-up of 5.4 (IQR 2.2-9.5) years, MAE occurred in 34 patients (13%). Large HM was associated with a lower incidence of MAE (hazard ratio 0.31, 95% confidence interval 0.1-0.8, P = 0.001). After multivariate adjustment for history of MAE, LVEF ≤35%, and scar ≥10%, large HM remained significantly associated with a lower incidence of MAE (P = 0.016). LVEF improved over time among patients with large HM (P = 0.006) but did not change in those without (P = 0.610) or small HM (P = 0.240).

CONCLUSION

HM conveys a lower risk of MAE in patients with ICM. This may be explained by an increase in LVEF when a large extent of HM is present.

摘要

目的

缺血性心肌病(ICM)患者主要心律失常事件(MAE)的已知预测因素包括既往MAE和左心室射血分数(LVEF)≤35%。通过灌注成像在ICM中检测到的心肌瘢痕与MAE有关,但冬眠心肌(HM)的预后意义尚不清楚。目的是通过13N-氨(NH3)和18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描/计算机断层扫描(PET/CT)联合检查预测ICM患者的MAE。

方法与结果

纳入连续接受NH3和FDG-PET/CT联合检查的ICM患者。HM相对于左心室总心肌进行定量(即≥7%为大面积)。主要结局是MAE[心源性猝死、植入式心律转复除颤器(ICD)治疗以及持续性室性心动过速/心室颤动]。在254例患者中,基线LVEF中位数为35%[四分位间距(IQR)28 - 45],10%的患者植入了ICD。PET/CT检查发现94例(37%)患者存在缺血,229例(90%)患者存在瘢痕,195例(77%)患者存在HM。在中位随访5.4(IQR 2.2 - 9.5)年期间,34例患者(13%)发生了MAE。大面积HM与较低的MAE发生率相关(风险比0.31,95%置信区间0.1 - 0.8,P = 0.001)。在对MAE病史、LVEF≤35%和瘢痕≥10%进行多变量调整后,大面积HM仍与较低的MAE发生率显著相关(P = 0.016)。大面积HM患者的LVEF随时间改善(P = 0.006),但无HM或小面积HM患者的LVEF无变化(P = 0.61)或小面积HM患者(P = 0.24)。

结论

HM在ICM患者中MAE风险较低。这可能是由于存在大面积HM时LVEF增加所致。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/363521421437/jeae232f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/a4d3e8e68092/jeae232_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/1becb38c0789/jeae232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/4db594c9314e/jeae232f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/363521421437/jeae232f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/a4d3e8e68092/jeae232_ga.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/1becb38c0789/jeae232f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/4db594c9314e/jeae232f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0675/11687117/363521421437/jeae232f3.jpg

相似文献

1
Prediction of major arrhythmic outcomes in ischaemic cardiomyopathy: value of hibernating myocardium in positron emission tomography/computed tomography.缺血性心肌病主要心律失常结局的预测:正电子发射断层扫描/计算机断层扫描中冬眠心肌的价值
Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):30-37. doi: 10.1093/ehjci/jeae232.
2
Myocardial Scar But Not Ischemia Is Associated With Defibrillator Shocks and Sudden Cardiac Death in Stable Patients With Reduced Left Ventricular Ejection Fraction.心肌瘢痕但无缺血与左心室射血分数降低的稳定患者的除颤器电击和心源性猝死相关。
JACC Clin Electrophysiol. 2018 Sep;4(9):1200-1210. doi: 10.1016/j.jacep.2018.06.002. Epub 2018 Jul 25.
3
Impact of denervated myocardium on improving risk stratification for sudden cardiac death.失神经支配心肌对改善心脏性猝死风险分层的影响。
Trans Am Clin Climatol Assoc. 2014;125:141-53; discussion 153.
4
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.心脏正电子发射断层扫描增强了疑似心脏结节病患者的预后评估。
J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16.
5
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.左心室收缩功能障碍患者血运重建治疗获益的鉴定:诱发性缺血与冬眠心肌。
Circ Cardiovasc Imaging. 2013 May 1;6(3):363-72. doi: 10.1161/CIRCIMAGING.112.000138. Epub 2013 Apr 17.
6
Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy.区域性心肌交感神经去神经支配可预测缺血性心肌病患者发生心原性猝死的风险。
J Am Coll Cardiol. 2014 Jan 21;63(2):141-9. doi: 10.1016/j.jacc.2013.07.096. Epub 2013 Sep 25.
7
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.有功能障碍但存活的心肌量可预测缺血性心肌病和左心室功能障碍患者的长期生存。
Int J Cardiovasc Imaging. 2013 Oct;29(7):1645-53. doi: 10.1007/s10554-013-0254-2. Epub 2013 Jun 7.
8
Myocardial Fibrosis Assessment by LGE Is a Powerful Predictor of Ventricular Tachyarrhythmias in Ischemic and Nonischemic LV Dysfunction: A Meta-Analysis.钆增强 MRI 评估心肌纤维化是缺血性和非缺血性左心室功能障碍患者室性心律失常的有力预测因素:一项荟萃分析。
JACC Cardiovasc Imaging. 2016 Sep;9(9):1046-1055. doi: 10.1016/j.jcmg.2016.01.033. Epub 2016 Jul 20.
9
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.
10
Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.采用 Tc-99m sestamibi SPECT 和 F-18 FDG PET 分析缺血性心肌病患者左心室机械不同步及预测价值。
Int J Cardiovasc Imaging. 2020 Oct;36(10):2063-2071. doi: 10.1007/s10554-020-01904-7. Epub 2020 Jun 3.

引用本文的文献

1
Cardiovascular imaging in 2024: review of current research and innovations.2024年心血管成像:当前研究与创新综述
Eur Heart J Imaging Methods Pract. 2025 May 17;3(1):qyaf066. doi: 10.1093/ehjimp/qyaf066. eCollection 2025 Jan.

本文引用的文献

1
Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial.缺血性左心室功能障碍患者经皮血运重建术后心律失常和死亡:REVIVED-BCIS2 试验的预设分析。
Circulation. 2023 Sep 12;148(11):862-871. doi: 10.1161/CIRCULATIONAHA.123.065300. Epub 2023 Aug 9.
2
Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death.用于室性心律失常和心源性猝死风险分层的高级成像技术。
Front Cardiovasc Med. 2022 Aug 22;9:884767. doi: 10.3389/fcvm.2022.884767. eCollection 2022.
3
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction.
缺血性左心室功能障碍的经皮血管重建术。
N Engl J Med. 2022 Oct 13;387(15):1351-1360. doi: 10.1056/NEJMoa2206606. Epub 2022 Aug 27.
4
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.2022年欧洲心脏病学会室性心律失常患者管理和心脏性猝死预防指南
Eur Heart J. 2022 Oct 21;43(40):3997-4126. doi: 10.1093/eurheartj/ehac262.
5
Myocardial viability testing: all STICHed up, or about to be REVIVED?心肌活力检测:全都“缝合”好了,还是即将“复苏”?
Eur Heart J. 2022 Jan 13;43(2):118-126. doi: 10.1093/eurheartj/ehab729.
6
Prognostic Value of Quantitative Metrics From Positron Emission Tomography in Ischemic Heart Failure.正电子发射断层扫描定量指标对缺血性心力衰竭的预后价值。
JACC Cardiovasc Imaging. 2021 Feb;14(2):454-464. doi: 10.1016/j.jcmg.2020.05.033. Epub 2020 Aug 5.
7
Ischaemic cardiomyopathy. Pathophysiological insights, diagnostic management and the roles of revascularisation and device treatment. Gaps and dilemmas in the era of advanced technology.缺血性心肌病。病理生理见解、诊断管理以及血运重建和器械治疗的作用。先进技术时代的差距与困境。
Eur J Heart Fail. 2020 May;22(5):789-799. doi: 10.1002/ejhf.1747. Epub 2020 Feb 5.
8
Stunned and Hibernating Myocardium: Where Are We Nearly 4 Decades Later?顿抑心肌和冬眠心肌:近40年后我们进展如何?
J Am Heart Assoc. 2020 Feb 4;9(3):e015502. doi: 10.1161/JAHA.119.015502.
9
No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy.顿抑心肌与冬眠心肌的静息心肌血流无差异:对缺血性心肌病病理生理学的深入了解。
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2322-2328. doi: 10.1007/s00259-019-04440-2. Epub 2019 Jul 29.
10
Role of quantitative myocardial blood flow and N-ammonia washout for viability assessment in ischemic cardiomyopathy.定量心肌血流和 N-氨清除在缺血性心肌病存活评估中的作用。
J Nucl Cardiol. 2021 Feb;28(1):263-273. doi: 10.1007/s12350-019-01684-1. Epub 2019 Mar 20.